These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36493725)

  • 1. Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.
    Bonfiglio F; Lasorsa VA; Cantalupo S; D'Alterio G; Aievola V; Boccia A; Ardito M; Furini S; Renieri A; Morini M; Stainczyk S; Westermann F; Paolella G; Eva A; Iolascon A; Capasso M
    EBioMedicine; 2023 Jan; 87():104395. PubMed ID: 36493725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline pathogenic variants in 786 neuroblastoma patients.
    Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani N; Dymek M; Desai H; Hausler R; ; ; ; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
    medRxiv; 2023 Jan; ():. PubMed ID: 36747619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.
    Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY
    BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of GALNT14 as a novel neuroblastoma predisposition gene.
    De Mariano M; Gallesio R; Chierici M; Furlanello C; Conte M; Garaventa A; Croce M; Ferrini S; Tonini GP; Longo L
    Oncotarget; 2015 Sep; 6(28):26335-46. PubMed ID: 26309160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
    Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
    Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children.
    Bae JS; Lee JW; Yoo JE; Joung JG; Yoo KH; Koo HH; Song YM; Sung KW
    Cancer Res Treat; 2020 Oct; 52(4):1251-1261. PubMed ID: 32599975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
    Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
    Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
    Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
    Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition and chromosome instability in neuroblastoma.
    Tonini GP; Capasso M
    Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
    Altun Z; Yuan H; Baran B; Aktaş S; Sönmez EE; Küçük C; Olgun N
    Gene; 2023 Apr; 860():147233. PubMed ID: 36736507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.
    Bestetti I; Barbieri C; Sironi A; Specchia V; Yatsenko SA; De Donno MD; Caslini C; Gentilini D; Crippa M; Larizza L; Marozzi A; Rajkovic A; Toniolo D; Bozzetti MP; Finelli P
    Hum Reprod; 2021 Oct; 36(11):2975-2991. PubMed ID: 34480478
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Formicola D; Lasorsa VA; Cantalupo S; Testori A; Cardinale A; Avitabile M; Diskin S; Iolascon A; Capasso M
    HGG Adv; 2023 Jan; 4(1):100158. PubMed ID: 36425957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
    Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
    Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition Workshop.
    Kamihara J; Diller LR; Foulkes WD; Michaeli O; Nakano Y; Pajtler KW; Perrino M; Scollon SR; Stewart DR; Voss S; Weksberg R; Hansford JR; Brodeur GM
    Clin Cancer Res; 2024 Aug; 30(15):3137-3143. PubMed ID: 38860978
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
    Romania P; Castellano A; Surace C; Citti A; De Ioris MA; Sirleto P; De Mariano M; Longo L; Boldrini R; Angioni A; Locatelli F; Fruci D
    PLoS One; 2013; 8(10):e78481. PubMed ID: 24205241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHOX2B mutations and genetic predisposition to neuroblastoma.
    Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
    Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
    Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
    BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.
    Egolf LE; Vaksman Z; Lopez G; Rokita JL; Modi A; Basta PV; Hakonarson H; Olshan AF; Diskin SJ
    Am J Hum Genet; 2019 Sep; 105(3):658-668. PubMed ID: 31474320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.